SARS-Cov-2

Changes in gene expression patterns in the brain associated with natural aging also were observed in the brains of those with severe COVID-19, prompting researchers to emphasize the need for neurological follow-up in recovered individuals.

Patients with PTSD who were diagnosed with COVID-19 were more likely to be hospitalized or die, compared with those without a psychiatric disorder, researchers reported in Translational Psychiatry.

Thirty-one percent of American adults expect to feel stressed about the upcoming holiday season, an increase of 9 percentage points from 2021, according to a poll from the American Psychiatric Association.

The bivalent COVID-19 booster vaccine from Pfizer-BioNTech elicited a stronger response against the BQ.1.1 sublineage than the companies’ original vaccine in people aged 55 years and older, according to new data from the companies.

SARS-CoV-2-related neurologic effects endured among children and adolescents in the United States who were hospitalized in 2021 for COVID-19 or multisystem inflammatory syndrome, researchers reported in JAMA Neurology.

CHICAGO — COVID-19-induced hyposmia eliminated odor-induced migraine headaches in an older adult, a case study presented at the 2022 American Neurological Association’s annual meeting showed.

Prior SARS-CoV-2 infection was associated with coronary vasomotor dysfunction, regardless of whether the patient required hospitalization, according to a brief communication published in the Journal of the American Heart Association.

WASHINGTON — Some infants with in utero or early life exposure to SARS-CoV-2 had borderline to low developmental scores, a study found, and this was most common among babies born to mothers with symptomatic COVID-19.

Long COVID can cause multisystem health issues that can last anywhere from months to years. We asked Farha S. Ikramuddin, MD, MPH, assistant professor in the department of rehabilitation medicine at the University of Minnesota Medical School, what the most significant consequence of long COVID will be moving forward.

Those who survive 30 days of SARS-CoV-2 infection have an increased risk for neurological disorders after 1 year compared with those who were not infected, according to a report in Nature Medicine.